Written Question·Department of Health and Social Care·UIN 36736
NHS: Drugs
Tabled: 10 March 2025
Answered: 17 March 2025
Question
Preet Kaur Gill
Labour (Co-op) — Birmingham Edgbaston
To ask the Secretary of State for Health and Social Care, what performance improvement targets he has sought from the MHRA on bringing down the licensing backlog of generic and biosimilar medicine applications.
Answer
Karin SmythThe Medicines and Healthcare products Regulatory Agency’s (MHRA) focus has been to ensure all applications received through all routes are processed on time. The MHRA has now embedded improvements in processing licencing applications into standard working...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 36736) →